Facebook
Twitter
Telegram
Report an ErrorIntellia Therapeutics Financial Statements 2011-2024 | NTLA
Annual Financial Statements Intellia Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.43 B | 2.98 B | 6.7 B | 3.51 B | 563 M | 593 M | 935 M | 279 M | - | - | - | - | - |
Shares |
88.8 M | 77 M | 70.9 M | 56 M | 47.2 M | 43.1 M | 36 M | 22.2 M | - | - | - | - | - |
Historical Prices |
27.4 | 38.8 | 94.6 | 62.6 | 11.9 | 14.1 | 25.7 | 12.9 | - | - | - | - | - |
Net Income |
-481 M | -474 M | -268 M | -134 M | -474 M | -85.3 M | -67.5 M | -31.6 M | -12.4 M | - | - | - | - |
Revenue |
36.3 M | 52.1 M | 33.1 M | 58 M | 43.1 M | 30.4 M | 26.1 M | 16.5 M | 6.04 M | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-515 M | -458 M | -268 M | -137 M | -106 M | -90.9 M | -69.6 M | -32.2 M | -13.4 M | - | - | - | - |
Interest Expense |
34.1 M | -16 M | -42 K | 2.35 M | 6.84 M | - | - | - | - | - | - | - | - |
EBITDA |
-506 M | -451 M | -261 M | -130 M | -101 M | -86.4 M | -66.6 M | -31.1 M | -13.1 M | - | - | - | - |
Operating Expenses |
- | - | - | - | - | 121 M | 95.7 M | 48.6 M | - | - | - | - | - |
General and Administrative Expenses |
116 M | 90.3 M | 71.1 M | 44.2 M | 41.1 M | 32.2 M | 28 M | 16.8 M | 8.28 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Intellia Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
95.5 M | 93 M | 88.6 M | 88.2 M | 87.8 M | 87.1 M | 76 M | 75.8 M | 74.8 M | 74.5 M | 73.7 M | 68.2 M | 67.2 M | 61.3 M | 58.8 M | 53.4 M | 50.5 M | 49.4 M | 48.6 M | 45.8 M | 45.2 M | 44.2 M | 43.2 M | 42.8 M | 42 M | 39.2 M | 35.2 M | 34.9 M | 34.7 M | 34.5 M | 34.3 M | 19.1 M | 676 K | 548 K | 294 K | 1.28 M | 1.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-107 M | - | -122 M | -124 M | -103 M | - | -113 M | -101 M | -147 M | - | -71.6 M | -68.8 M | -46.2 M | -42.2 M | -27.8 M | -32.4 M | -31.8 M | -28.3 M | -23.6 M | -25.7 M | -21.9 M | -19.1 M | -22.7 M | -22.2 M | -21.4 M | -24 M | -15.4 M | -15.6 M | -12.6 M | -10.6 M | -7.48 M | -6.9 M | -6.69 M | -5.24 M | -3.02 M | -3.04 M | -1.09 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
28.9 M | - | 12 M | 13.6 M | 12.6 M | - | 13.3 M | 14 M | 11.3 M | - | 7.2 M | 6.55 M | 6.44 M | 6.6 M | 22.2 M | 16.3 M | 12.9 M | 10.9 M | 10.6 M | 11.1 M | 10.4 M | 7.88 M | 7.41 M | 7.68 M | 7.47 M | 6.67 M | 7.32 M | 5.92 M | 6.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-114 M | - | -131 M | -132 M | -112 M | - | -106 M | -98.3 M | -144 M | - | -72 M | -69 M | -46.4 M | -42.4 M | -28.1 M | -33 M | -33 M | -29.8 M | -25.3 M | -27.5 M | -23.8 M | -20.7 M | -24.1 M | -23.6 M | -22.4 M | -24.7 M | -15.9 M | -16 M | -12.9 M | -10.8 M | -7.7 M | -6.95 M | -6.69 M | -5.49 M | -3.3 M | -3.42 M | -1.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
6.57 M | - | 8.88 M | 8.65 M | 8.83 M | - | -7.7 M | -2.38 M | -2.63 M | - | 349 K | - | 220 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-111 M | - | - | - | -110 M | - | -100 M | -98.3 M | -142 M | - | -67 M | -69 M | -44.8 M | -42.4 M | -23.4 M | -29.9 M | -31.5 M | -29.8 M | -21.3 M | -24.8 M | -22.5 M | -20.7 M | -20.9 M | -21.5 M | -21.4 M | -24.7 M | -13.7 M | -14.6 M | -12.3 M | -10.8 M | -7 M | -6.51 M | -6.51 M | -5.49 M | -3.1 M | -3.32 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
31.1 M | - | 29.4 M | 30.7 M | 27.4 M | - | 22.1 M | 22.1 M | 22.4 M | - | 18.7 M | 16.7 M | 13.6 M | 10.8 M | 10.6 M | 11.5 M | 11.3 M | 8.98 M | 8.43 M | 13.1 M | 10.5 M | 8.71 M | 8.27 M | 7.8 M | 7.41 M | 10.2 M | 5.71 M | 6.37 M | 5.73 M | 5.12 M | 4.7 M | 3.73 M | 3.25 M | 2.81 M | 1.53 M | 2.83 M | 1.11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency